Zhu H, Jaime A, Pranatartiharan R, Abraham B, Steve W, Rolf P, Roderick T Bronson, et al. (2009) Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis Proceedings of the National Academy of Sciences 106, no.8: 2712-2716.
Joo, Kyeung M, Shi Yean K, Xun J, Sang Yong S, Doo-Sik K, Jung-II L, Ji Won J, et al. (2008) Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Laboratory investigation 88, no.8: 808-815.
Verhaak GW, Hoadley K, Purdom E, Victoria W, Qi Y, Wilkerson M, Miller RM, et al. (2010) Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities Cancer cell 17, no.1: 98-110.
Liang Y, Maximilian D, Watson N, Bollen A, Aldape KD, Nicholas KM, Lamborn KR, et al. (2005) Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme." Proceedings of the National Academy of Sciences of the United States of America 102, no.16: 5814-5819.
Phillips H, Samir K, Ruihuan C, Forrest WF, Soriano RH, Wu TD, Misra A, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis." Cancer cell 9, no.3: 157-173.
Mischel PS, Shai R, Tao S, Horvath S, Lu KV, Choe G, Seligson D, et al. (2003) Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene. 22, no.15: 2361-2373.
Hegi ME, Diserens AE, Gorlia T, Hamou MF, Tribolet N, Weller N, Kros JM, et al. (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma." New England Journal of Medicine. 352, no.10: 997-1003
Iorio MV, and Croce CM (2009) MicroRNAs in cancer: small molecules with a huge impact. Journal of Clinical Oncology 27.34: 5848-5856
Griffiths-Jones S, Harpreet KS, Stijn van D and Enright AJ (2008) miRBase: Tools for microRNA genomics. Nucleic acids research 36, no. suppl 1: D154-D158.
Zhang Y, Pengyuan Y, Tao S, Dong L, Xin X, Yaocheng R, Chaoran L, et al. (2013) miR-126 and miR-126 repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nature cell biology 15, no.3: 284-294.
Li J, Zhang P, and Hui N (2012) MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer. International journal of molecular sciences 13.12: 16053-16064.
Baffa R, Matteo F, Stefano V, O'Hara B, Chang-Gong L, Palazzo JP, Gardiman M, et al. (2009) MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. The Journal of pathology 219, no.2: 214-221.
Zhang Y, Pengyuan Y, Tao S, Dong L, Xin X, Yaocheng R, Chaoran L, et al. (2013) miR-126 and miR-126∗ repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nature cell biology 15, no.3: 284-294.
Olarerin-G, Anthony O, Lauren A, Yih-Chii H, Michal AE, and Hogenesch JB (2013) A functional genomics screen for microRNA regulators of NF-kappaB signaling. BMC biology 11, no.1: 19
Graeber TG, Heath JR, Skaggs JB, Phelps ME, Remacle F and Levine RD (2010) Maximal entropy inference of oncogenicity from phosphorylation signaling. Proceedings of the National Academy of Sciences 107, no.13: 6112-6117.
Remacle F, Kravchenko-Balasha N, Levitzki A, and Levine RD (2010) Information-theoretic analysis of phenotype changes in early stages of carcinogenesis." Proceedings of the National Academy of Sciences 107, no.22: 10324-10329.
Kravchenko-Balasha N, Remacle F, Gross A, Rotter V, Levitzki A, Levine RD (2011) Convergence of logic of cellular regulation in different premalignant cells by an information theoretic approach. BMC systems biology 5:42
Kravchenko-Balasha N, Levitzki A, Goldstein A, Rotter V, Gross A, Remacle F, Levine RD (2012) On a fundamental structure of gene networks in living cells. Proceedings of the National Academy of Sciences 109, no.12: 4702-4707.
Zisoulis DG, Zoya SK, Chang RK, Pasquinelli AE (2012) Autoregulation of microRNA biogenesis by let-7 and Argonaute. Nature 486, no.7404: 541-544.
Nass D, Shai R, Eti M, Shlomit G, Tabibian-Keissar H, Schlosberg A, Kuker H, et al. (2009) MiR-92b and miR-9/9.∗ are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors." brain pathology 19, no.3: 375-383.
Ma L, Young J, Harsha P, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis." Nature cell biology 12, no.3: 247-256.
Holter NS, Madhusmita M, Amos M, Marek C, Banavar JR, Fedoroff NV (2000) Fundamental patterns underlying gene expression profiles: simplicity from complexity. Proceedings of the National Academy of Sciences 97, no.15: 8409-8414.
Papagiannakopoulos T, Shapiro A, Kosik KS. (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Research 68.19: 8164-8172.
Fowler A, Thomson D, Giles K, Maleki S, Mreich E, Wheeler H, Leedman P, et al. (2011) miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion." European Journal of Cancer 47, no.6: 953-963.
Haldar S, Basu A. (2011) Modulation of MicroRNAs by Chemical Carcinogens and Anticancer Drugs in Human Cancer: Potential Inkling to Therapeutic Advantage. Molecular and cellular pharmacology 3.3: 135.
Simon R, Radmacher MD, Dobbin K, McShane LM (2003) Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. Journal of the National Cancer Institute 95, no.1: 14-18.
Remacle F, Kravchenko-Balasha N, Levitzki A, Levine RD (2010) Informationtheoretic analysis of phenotype changes in early stages of carcinogenesis. Proceedings of the National Academy of Sciences 107, no.22: 10324-10329.
Zadran S, Standley S, Wong K, Otiniano E, Amighi A, Baudry M (2012) Fluorescence resonance energy transfer (FRET)-based biosensors: visualizing cellular dynamics and bioenergetics. Applied microbiology and biotechnology 96, no.4: 895-902.
Gupta PB, Fillmore CM, Guozhi J, Sagi DS, Kai T, Kuperwasser C, Lander ES (2011) Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, no.4: 633-644.
Sun J, Xue G, Puro B, Zhao Z (2012) Uncovering microRNA and transcription factor mediated regulatory networks in glioblastoma. PLoS computational biology 8, no.7: e1002488.
Karsy M, Erol A, Moy F (2012) Current progress on understanding microRNAs in glioblastoma multiforme. Genes & cancer 3.1: 3-15.
Hua D, Fan M, Dong D, Li L, Xu H, Zhao H, Foltz G, Lin B, Lan Q, Huang Q (2012) A catalogue of glioblastoma and brain MicroRNAs identified by deep sequencing. Omics: A journal of integrative biology 16, no.12: 690-699.
Costa PM, Cardoso AL, Pereira de Almeida LR, Bruce JR, Canoll P, Pedroso de Lima MC (2012) PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma. Human molecular genetics 21, no.23: 5118-5130.
Costa PM, Cardoso AL, Clévio N, Pereira de Almeida LR, Bruce JN, Canoll P, Pedroso de Lima MC (2012) MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma. Human molecular genetics: dds496.
Kim Y, Soyeon R, Lawler S, Friedman A (2011) miR451 and AMPK mutual antagonism in glioma cell migration and proliferation: A mathematical model. PloS one 6, no.12: e28293.
Kefas B, Jakub G, Laurey C, Yunqing L, Roger A, Hawkinson M, Jeongwu L, et al (2008) microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer research 68, no.10: 3566-3572.
Qiu S, Sheng L, Dan H, Yimin F, Yang T, Ying P (2013) Interactions of miR- 323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. J Transl Med 11, no.10: 10-1186.
